US company Aimlock has been all about deadly accurate fire. Now it's also making last-resort weapons for the counter-drone fight.
Its targeting systems have been applied to everything from rifles to rockets and various drones.
CEO Bryan Bockman told BI about AimLock's work in the counter-UAS space at SOF Week 2025.
Helping troops armed with rifles, drones, mounted machine guns, and even grenade and rocket launchers identify and lock onto targets more easily — that's the basic mission of US company AimLock, which has been developing automated targeting products for over a decade.
At SOF Week 2025, the company's CEO, Bryan Bockmon, told Business Insider about how the company is now focusing on autonomous weapons systems that may be crucial for future warfare, systems made for defeating drones. Countering drones is an expanding area of research and development, with a lot of work being done in Ukraine, though that isn't the only country where this technology is being developed.
The Ukraine war has shown that electronic warfare like signal jamming and GPS spoofing can be effective when it comes to defeating enemy drones, but having a kinetic option, the ability to shoot it, as a last resort for destroying those systems is essential should other options fail.
And they may fail because some drones, like the fiber-optic drones becoming more common in Ukraine or AI-enabled systems, for instance, are resistant to electronic warfare.
"If that doesn't work," Bockmon said of electronic warfare, then "this is the last line of defense."
AimLock's autonomous counter-drone systems are made to detect classify, and track uncrewed aerial systems and then decide on the best firing solution for taking them out.
One of the AimLock counter-UAS systems was on display at SOF Week in Tampa, Florida. Bockmon said that the system was invulnerable to signal jamming and other elements of electronic warfare because it relies on visual navigation and autonomous terminal guidance.
"We develop autonomy that's specialized for weapons integration," the CEO said, explaining that the autonomy is in finding targets, aiming, tracking, and engagement, or actually firing the weapon at the target.
What makes AimLock's development approach interesting is that "instead of making specialized systems that then have to be reinvented 10 times over to cover the entire mission need," Bockmon said, it makes "generalized modules that can be adapted across 10 different missions."
So if the warfighter needs a different sensor or weapon system, it can find an AimLock product to match. It reduces the development cycle, the CEO said, lowering costs and simplifying the process.
The company's Core Targeting Module, or CTM, as it's called, is at the heart of AimLock's systems. It combines autonomy and firing and targeting components to improve the speed and precision of weapons from guns to uncrewed systems.
The CTM hardware is, in some cases, just a small black box with a few plug-in outlets on top.
Bockmon said the modularity of it and other weapons systems AimLock makes allows it "to offer new solutions that can adapt at the pace of combat," whether that is a low-intensity fight or a high-intensity great power conflict in remote or contested environments with limited communications.
While the company has been working to refine all of this for years, its current focus is its counter-drone systems.
Counter-drone technology has been growing in importance for years now with electronic warfare, directed energy (lasers), and other developments all aimed at defeating uncrewed systems, but the technology is becoming critical as drones, especially small, inexpensive drones, become more prolific. The Pentagon unveiled its new counter-UAS strategy to address these issues last year, but there's a lot of work to be done to meet the threat.
"We finished our first counter-UAS systems back in 2018," Bockmon explained to BI, "and they had to sit on the shelves for a long time because it was really about how effective will electronic warfare be in the future, and then how quickly will it be defeated." It wasn't clear initially how effective electronic warfare would be, but it's clear now that it's not infallible.
The counter-drone mission was a big topic at SOF Week 2025. Multiple defense industry exhibitors and special operations officials spoke to the growing need for a variety of solutions to defeat hostile drones. The Defense Department has made developing a military-wide strategy for countering drones a top priority.
Read the original article on Business Insider
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
MoonLake Immunotherapeutics (MLTX): A Bull Case Theory
We came across a bullish thesis on MoonLake Immunotherapeutics on by skimmer610. In this article, we will summarize the bulls' thesis on MLTX. MoonLake Immunotherapeutics's share was trading at $51.89 as of August 7th. Pressmaster/ MoonLake Immunotherapeutics (MLTX) represents a high-upside, asymmetric biotech opportunity ahead of its critical September 2025 Phase 3 readout (VELA) in hidradenitis suppurativa (HS). The company's lead asset, sonelokimab—a tri-specific nanobody that blocks IL-17A/F and binds albumin—has shown best-in-class Phase 2 efficacy in HS and psoriatic arthritis (PsA), with key advantages in potency, safety, and tissue penetration. Backed by ~$480M in cash and a non-dilutive $500M credit facility, MLTX has a clean balance sheet with no need for near-term funding. The company's modest ~$2.5B enterprise value offers substantial upside should VELA succeed, with peak HS sales estimates of $1.5–2.0B and an additional $1–2B optionality from PsA and other indications. Notably, sonelokimab demonstrated a 29-point HiSCR-75 delta over placebo in HS and beat Humira in multiple PsA metrics. Its safety profile is clean, avoiding the class-wide issues seen with brodalumab and Bimzelx. MoonLake's strategic focus on IL-17-driven diseases resistant to TNF inhibitors, combined with a well-patented and hard-to-replicate nanobody platform, creates meaningful barriers to entry. With full Phase 3 enrollment already completed and a Data Safety Monitoring Board update expected in Q3 2025, investors face a clear near-term catalyst path. If successful, MLTX could be an M&A target, with Merck previously showing interest. Even in the base case of HS success alone, the company could trade 3–5x higher. Downside risk is meaningful if VELA disappoints, but strong Phase 2 data, a robust manufacturing platform, and a focused pipeline mitigate concerns. MLTX offers a compelling risk/reward with transformative upside potential. Previously, we covered a bullish thesis on Bio-Techne Corporation (TECH) by scuttleblurb in May 2025, which highlighted the company's expansion from legacy protein products into CGT, diagnostics, and proteomics. The company's stock price has appreciated by approximately 10% since our coverage. This is because organic growth and instrument sales rebounded. skimmer610 shares a distinct but emphasizes MoonLake's focused, binary biotech catalyst and asymmetric upside ahead of its HS readout. MoonLake Immunotherapeutics is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 38 hedge fund portfolios held MLTX at the end of the first quarter which was 32 in the previous quarter. While we acknowledge the potential of MLTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
On Holding AG (ONON) Is One Of My Favorite Companies, Says Jim Cramer
We recently published . On Holding AG (NYSE:ONON) is one of the stocks Jim Cramer recently discussed. On Holding AG (NYSE:ONON) is a Swiss athletic apparel retailer. Its shares have dipped by 19% year-to-date, primarily due to inflationary effects on the demand for its products. However, despite the weak share performance, Cramer has remained upbeat about On Holding AG (NYSE:ONON) as he believes that the firm has the potential to rise from any major setback. Here are his recent thoughts about the firm: 'One of my favorite companies is On Holding. Now it has been stuck in a holding pattern. They reported very good numbers today, the stock was initially up seven, now it's down. There's a substantial short position, the shorts have been winning in this battle. I think Roger Federer in the end wins. But it is a very contested group.' Copyright: halfpoint / 123RF Stock Photo Here are Cramer's previous thoughts about On Holding AG (NYSE:ONON): 'You know, let me tell you something, the reason why I like the stock is that they have adjusted every time that there's been a problem. Roger Federer and his team have adjusted, and I think that if there's really something that's lasting and negative, they will fix it, which is one of the reasons why I do like On. I am concerned that Nike may be making a comeback and take business from On, but I think On is a decent buy here.' While we acknowledge the potential of ONON as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Fashion giants Shein and Temu in hot water after secret shopper investigation: 'Shocked'
Fashion giants Shein and Temu in hot water after secret shopper investigation: 'Shocked' Online fast-fashion giants Shein and Temu are facing pressure from European regulators after a secret shopper investigation uncovered serious safety violations in a range of their products. What's happening? The European Commission is cracking down on Shein and Temu after discovering dangerous and noncompliant products sold through the platforms. These include baby teethers with choking hazards, sunglasses with no UV protection, and children's raincoats laced with toxic chemicals. A report from members of the European Parliament also found banned substances linked to fertility and developmental harm in cosmetics sold on the sites. EU Justice Commissioner Michael McGrath said he was "shocked" by the findings, as reported by Euro Weekly News. This news is surfacing as the EU struggles to manage an overwhelming influx of imported goods. In 2024, the bloc received 4.6 billion cheap shipments under €150, double the number from the year before. Why are discount and fast-fashion retailers such as Temu and Shein concerning? These violations are putting people at risk. From toxic chemicals to unsafe children's products, the quality issues show how ultra-cheap imports are more dangerous and problematic than people think. In 2023, the EU issued a record 4,137 alerts for unsafe nonfood products. Shein's and Temu's business models are also concerning. Many of their items aren't made to last, feeding into the global mountain of landfill waste. About 101 million tons of textile waste are generated every year. And in the U.S., about 85% of all textiles end up in the dump each year. To make things worse, European companies that play by the rules face higher compliance costs, putting them at a disadvantage compared with low-cost international sellers skirting regulations. What's being done about it? In response, the EU is considering removing the €150 duty-free threshold and introducing a per-package fee to better fund customs, which is already being overwhelmed by the sheer number of orders. McGrath also plans to raise the issue with Chinese officials at the upcoming EU-China summit. Shein has responded by pointing to its compliance investments, and Temu shared a report about its seller vetting and compliance checks. But so far, EU officials remain unconvinced. Consumers can do plenty to curb the environmental effects of fast fashion and cheap retailers. First, rethink your shopping habits. Shopping secondhand can save money while cutting waste. Plus, thrifters often find luxury or valuable items at dirt-cheap prices. Learn about better alternatives in this guide to breaking up with fast fashion. While the scale of the issue is massive, awareness and action from everyday shoppers can help hold retailers accountable for the true cost of cheap goods. Which of these factors would most effectively motivate you to recycle old clothes and electronics? Giving me money back Letting me trade for new stuff Making it as easy as possible Keeping my stuff out of landfills Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword